Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOMAB BIO-B

2.850
+0.85042.50%
Volume:60.46M
Turnover:149.99M
Market Cap:3.43B
PE:-15.13
High:2.990
Open:2.300
Low:2.200
Close:2.000
Loading ...

Company Profile

Company Name:
SINOMAB BIO-B
Exchange:
SEHK
Establishment Date:
2001
Employees:
95
Office Location:
No.15 Science Park West Avenue,Units 303 and 305-307,Hong Kong Science Park,Pak Shek Kok,Tai Po,New Territories,Hong Kong
Zip Code:
- -
Fax:
852 3426 9433
Introduction:
SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Company’s product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogren’s syndrome (SS) and other immunological diseases.

Directors

Name
Position
LIANG Rui An
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
WANG Shan Chun
Executive Director
Dylan Carlo TINKER
Independent Director,Member of the Nomination Committee,Audit Committee Member
HAN Bing Zu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
George William Hunter CAUTHERLEY
Independent Director,Audit Committee Member
LI Zhi Ming
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
CHEN Hai Gang
Director
DONG Xun
Director
ZHANG Jian Min
Director
WANG Xiao Su
Director

Shareholders

Name
Position
LIANG Rui An
CEO
WANG Shan Chun
General Manager
HUA Jian Ping
CFO
ZHANG Yuan De
CMO
QIAO Jie
Assistant to the General Manager
ZHOU Yu Yan
Corporate Secretary
XU Guo Lin
Other Senior Executives
ZHANG Jia Hua
Other Senior Executives